IL6 and arthritic joint disease: In our Risk-RA cohort the finding of increased levels of IL-6 in the Risk-RA phase, something also seen in Pre-RA studies [24, 32], is a sign of inflammation in individuals progressing to arthritis, although the levels are comparable to the levels in healthy controls (Supplementary Fig. S3, available at Rheumatology online).